Latest News
vivoVerse awarded SBIR Phase II grant from NIEHS
vivoVerse is excited to announce it has been awarded a $1.83M Phase II SBIR grant from the National Institute of Environmental Health Sciences (NIEHS) for the continued development of the company’s in vivo imaging and screening technologies.
vivoVerse cofounders publish single-cell isolation method using femtosecond laser microdissection (fs-LM)
vvivoVerse cofounders Dr. Adela Ben-Yakar and Dr. Sudip Mondal have published an article in Nature Methods titled “Femtosecond laser microdissection for isolation of regenerating C. elegans neurons for single-cell RNA sequencing.” This publication...
Meeting report: A successful and enjoyable time at SOT2023 in Nashville for vivoVerse
The vivoVerse team recently attended the 2023 Society of Toxicology (SOT) Annual Meeting. It was a great time networking with people in the toxicology and safety testing industry...
More news...
